Humacyte Inc (HUMA)

1.17 +4.46%

Humacyte Inc (HUMA) is currently trading at $1.17. This represents a gain of 4.46% from the previous session. With a market capitalization of $0.23B, HUMA is a key component of the Health Care sector. Investors looking to trade HUMA should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade HUMA commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Humacyte Inc (HUMA) shows a bullish trend. Analysts are watching the 1.21 level closely.

Fundamentals
Mkt Cap0.23B
P/E Ratio0.0000
Volume4,238,767
Others Watching (By Market Cap)
CTKB
Cytek Bioscienc $4.36
-0.11% ALLO
Allogene Therap $2.49
+8.95% IRWD
Ironwood Pharma $3.40
-11.08% DNA
Ginkgo Bioworks $9.39
+5.98% ORGO
Organogenesis H $4.12
+2.36%
60-Day Technical Chart
Advanced Charting

Need more indicators for HUMA? Use the world's #1 platform.

Open HUMA on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $1
Metric HUMA
+4.46% 		ABTC
+3.43% 		AMC
+0.00% 		FUBO
+2.16%
Price $1.17 $1.06 $1.17 $1.20
Mkt Cap $0.23B $0.98B $0.62B $1.55B
- View → View → View →
Latest Headlines
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider Yahoo Finance • Feb 2, 2026 Pentagon backs lab-grown blood vessels for wounded troops Stock Titan • Feb 9, 2026 Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA) Seeking Alpha • Feb 9, 2026 Humacyte Stock (HUMA) Opinions on FDA Approval for Symvess Product Quiver Quantitative • Dec 11, 2025 Humacyte stock tumbles after $60 million registered direct offering Investing.com • Oct 7, 2025
● Gemini Agentic AI Analyst Insight for HUMA
Market Education
View All Articles →
External Research